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PAPER
Development of clinical ethics services in the UK:
a national survey
Anne Marie Slowther,1 Leah McClimans,2 Charlotte Price3
ABSTRACT
Background In 2001 a report on the provision of clinical
ethics support in UK healthcare institutions identified 20
clinical ethics committees. Since then there has been no
systematic evaluation or documentation of their work at
a national level. Recent national surveys of clinical ethics
services in other countries have identified wide variation
in practice and scope of activities.
Objective To describe the current provision of ethics
support in the UK and its development since 2001.
Method A postal/electronic questionnaire survey
administered to the chairs of all 82 clinical ethics
services registered with the UK Clinical Ethics Network in
July 2010.
Results Response rate was 62% with the majority of
responding services situated in acute trusts. All services
included a clinical ethics committee with one service also
having a clinical ethicist. Lay members were present in
72% of responding committees. Individual case
consultation has increased since 2001 with 29% of chairs
spending more than 50% of their time on this. Access to
and involvement in the process of case consultation is
less for patients and families than for clinical staff. There
is wide variation in committee processes and levels of
institutional support. Over half of the responding
committees undertook some form of evaluation.
Conclusion Clinical ethics services in the UK are
increasing as is their involvement in case consultation.
However, the significant variation in committee
processes suggests that further qualitative research is
needed to understand how these committees function
and the role they play in their institution.
INTRODUCTION
Although clinical ethics services (CESs) have been
a part of North American healthcare since the early
1970s,1 and in some European countries since the
1980s, clinical ethics committees (CECs) were first
described in the UK only in the mid-1990s.2 In 2001
Slowther et al identified 20 established CECs in the
UK3 and in the same year the UK Clinical Ethics
Network (UKCEN) was established to facilitate
CEC training, networking and to provide support
to CECs.4 In 2011 the number of CECs registered
with the network has risen to 84.5
In parallel with the development of CESs
worldwide there has been a continuing commen-
tary on the nature, goals and competencies of these
services, including critiques of their legitimacy and
effectiveness.6e8 The described activities of CESs
include individual case consultation where current
or retrospective cases are considered and recom-
mendations are provided to relevant individuals,
contributing as a member of the multidisciplinary
team, providing input into organisational policies,
promoting ethics leadership in the institution and
facilitating moral reflection and deliberation among
health professionals.4 9 10 The models of CES
provision and the institutional and political
contexts in which they operate are also diverse.11
CESs can manifest as CECs (as they typically do in
the UK), individual ethics consultants or even small
teams. This variation creates challenges for evalu-
ation of CESs. Previous suggestions for evaluation
criteria for clinical ethics services have included
the quality and efficiency of a service as well as the
access individuals have to it. The variation in
CESs makes it difficult to know precisely what
constitutes good quality, efficiency and access.12
A further challenge is the scarcity of good quality
empirical evidence on the functioning of CESs. A
small number of surveys of CESs in various coun-
tries have been published since 2005. Fox et al
surveyed a random sample of all US hospitals and
at each interviewed the ‘best informant’ on the
provision of an ethics consultation service.13 They
concluded that, although the prevalence of ethics
consultation services was high, there was a marked
variation in practice. Gaudine et al surveyed all
hospitals in Canada with over 100 beds and found
that 84% had a CEC.14 They noted the increasing
number of CECs over the previous 20 years, but
identified a need for research to define what the
scope of activities should be. Pedersen et al surveyed
all 24 CECs in Norwegian hospitals and conducted
qualitative group interviews with nine of them.15
They identified a need to improve processes, clarify
the committee’s role and secure adequate organ-
isational support. In 2009 Whitehead et al surveyed
70 UK CECs focusing on committee composition,
member qualifications and the number of active or
retrospective cases considered in the past year.16
They questioned whether the committee is the
appropriate model for CESs in the UK.
This empirical evidence of the variation in prac-
tice and the need to clarify the goals of CESs
highlights the importance of having a solid under-
standing of what is happening before developing
models of evaluation. We report here a national
survey of CESs in the UK with the aim of
describing the current provision of clinical ethics
support and its development since 2000. Specifi-
cally we looked at the following areas of interest:
< The structure of UK CESs.
< How UK CESs function in consultation,
education and policy review.
< An additional material is
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< The range of ethical issues that present to a CES in the UK.
< The level of institutional support for CESs in the UK.
METHOD
We developed a questionnaire with reference to the literature on
the evaluation of clinical ethics, including the descriptive
surveys conducted in USA and Canada.13 14 The questionnaire
was refined through six telephone interviews with selected
chairs of UK CECs. Their comments informed the development
of a final version which was piloted to test user acceptability and
time taken to complete. The final instrument contained 57
questions for chairs of CECs or groups and 40 questions for
individual clinical ethicists. The study was approved by
Warwick University Biomedical Research Ethics Committee.
Sample
The study population was the CESs registered with UKCEN.
Our experience in working with the network leads us to believe
that most if not all CESs in the UK are registered with UKCEN.
Data collection
In July 2010 the survey was sent electronically and by post to all
(N¼82) UK CESs known to UKCEN. A reminder was emailed to
all chairs 4 weeks after the original mailing with a follow-up
telephone reminder at 8 weeks. The information provided by
chairs was anonymous. Data collection concluded on 31 October
2010.
Data analysis
Data were entered into and analysed using SPSS V.18.0.
Descriptive statistics including frequencies with corresponding
percentages were used to summarise the survey results.
RESULTS
Of the 82 CESs registered with UKCEN, 51 completed the
survey (response rate 62%); (see supplementary online data). All
geographical regions were represented in the responses with the
exception of Scotland. The majority of responding CESs (32/50,
64%) were located in acute trusts (general hospitals) with five
services in a hospice, four in mental health trusts and four in
children’s hospitals (Q2). Five belonged to the ‘other ’ category
and one did not respond to this question. Two chairs noted links
between their service and primary care.
Description of clinical ethics services
The majority (43/51, 84%) of surveyed services had been active
for $4 years (Q3). Although 71% (36/51) of chairs reported
having some kind of administrative support, the amount of
support varied considerably ranging from 1 h per month to 15 h
per week (Q44, Q44a). When asked about avenues of account-
ability 22/51 (43%) chairs said they reported to the clinical
governance director (responsible for quality and governance in
clinical care), 18/51 (35%) reported to the trust (healthcare
institution) board and 19/51 (37%) reported to a medical
director (Q39). Some services reported more than one avenue of
accountability.
All the surveyed CESs were described as a ‘formal committee
or group with specific membership’ (Q4). One service described
an individual ethicist in addition to a formal committee. The
number of scheduled committee meetings ranged from two to
12 a year, with a median of six (Q5). Minimum duration of
scheduled meetings was reported as 60 min with 22/50 (44%)
responders to this question reporting meetings of longer than
90 min (Q7). Unscheduled meetings also occurred with 19 out of
41 responders (46%) reporting two or more unscheduled
meetings a year (Q6).
Committee membership numbers ranged from eight to 33
(median 16, interquartile range 12e20)(Q10). Committees were
multiprofessional with most (36/50, 72%) having lay member-
ship (Q11). A member with a legal background was reported by
36/50 (72%) committees (table 1). Forty-nine committees (all of
those who responded to the question) reported at least one
member with a masters or doctorate in clinical/medical ethics
(Q18). Not all members with an ethics qualification work as an
academic ethicist.
General procedures and practices
When asked about how new members are recruited chairs
reported using a range of strategies, often in combination (Q16).
Personal recommendation from a member of the committee was
the commonest method of recruitment (39/50, 78%) with
receipt of unsolicited requests from someone interested in being
on the committee (32/50, 64%) and advertising within the trust
(29/50, 58%) also used frequently. Only four committees
advertised externally for lay members. A selection process for
new members was reported by 30/49 (61%) committees.
Processes included interview (13/30, 43%), application form
(12/30, 40%) and/or CV (14/30, 47%) (Q17).
Functioning
Chairs of the service were asked how many hours a month were
devoted to CES work (Q19). Twenty-eight (55%) spent <5 h per
month on clinical ethics work, but 5/51 (10%) spent more than
15 h a month. Although there was some variation, the main
focus of chairs’ time was on case consultation with 14/49 (29%)
spending more than half of their time on this compared with 3/
48 (6%) who spent more than half of their time on education
and 5/48 (10%) who spent more than half of their time on policy
review (Q20).
Consultation
Over half (27/51, 53%) of the chairs reported receiving 1e5
requests for consultation in the previous 12 months and almost
a third (16/51, 31%) reported receiving 6e10 (Q21). Four services
had 11 or more requests and a further four reported not receiving
any consultation requests in the previous 12 months. Of the
Table 1 Membership of clinical ethics committees
Category
Number (%) of committees
with at least one member
in this category (N[50)
Nurse 46 (92)




General practitioner 18 (36)
Chaplain 42 (84)
Lay person 36 (72)
Profession allied to medicine 36 (72)
Hospital manager 28 (56)
Trust legal adviser 22 (44)
Lawyer other than trust legal adviser 20 (40)
Academic ethicist 30 (60)
Other 26 (52)
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43/49 (88%) chairs who reported having a mechanism for
semi-urgent or emergency requests, 28/43 (65%) reported
receiving 1e5 requests in the previous 24 months (Q32).
We defined two categories of consultation requests: institu-
tional consultation requests, which refer to organisational
ethical issues and requests focusing on individual clinical cases,
which refer to ethical issues involving a patient or family
member. Some services reported institutional consultation
requests about audit (7/51, 14%) or service evaluation (15/51,
29%) (Q22). The majority of consultation requests related
to clinical cases and table 2 shows the range of issues that
formed the basis of these requests over the previous 12 months
(Q27).
When asked about access to consultations, almost all chairs
reported accepting consultation requests from doctors (50/51,
98%) and nurses (48/51, 94%) with fewer accepting referrals
from non-clinical members of staffdfor example, social workers
and chaplains (42/51 82%) (Q23).Consultation requests were
accepted from patients and family members by 25/51 (49%)
services and 12 services placed no restriction on whom could
request a consultation. Several respondents commented that in
practice most consultation requests came from clinicians. Most
services accepted written referrals (44/51, 86%) and/or verbal
referrals (37/51, 73%) while 6/51 (12%) accepted referrals via
email (Q24). Standardised forms for referrals were used by 19/51
(37%) of committees. For semi-urgent or emergency consulta-
tions 42/45 (93%) services who responded to this question used
a small group model for consultation (Q30).
In gathering information for individual clinical case consul-
tations, 42/45 (93%) reported having a group meeting with one
or more members of clinical staff and 11/45 (24%) reported
including the patient in meetings (Q25). Individual meetings
were reported with members of clinical staff other than the
referrer (29/45, 64%) and with the patient and/or family (15/45,
33%). Just under half, 21/45 (47%), said that they examined the
patient’s medical records. When asked about the use of decision-
making frameworks, over half of the responders to this question
(28/50, 56%) reported using the ‘four principles’ approach in the
previous 12 months. Other less commonly used frameworks
were the Ethox approach (18/50, 36%), the Four Quadrant
approach (5/50, 10%) and the Dilemma method (3/50, 6%).
Some used more than one framework and 15/50 (30%) said that
they did not use any (Q26).
All responding chairs reported using consensus for arriving at
a conclusion or recommendation, although two also reported
sometimes voting on the outcome (Q33). Records of consulta-
tions were most commonly made in meeting minutes 45/51
(88%) with 30/51 (59%) keeping a separate consultation
summary and 17/51 (33%) making notes in the patient’s medical
records (Q34).
Education and policy review/development
Chairs identified a range of educational activities for clinical staff
organised or supported by the CES in the previous 12 months
including grand roundsdthat is, a formal presentation to the
trust community (29/51, 57%), conferences (23/51 45%) and
clinical unit seminars (18/51, 35%) (Q35). However, 41/51 (80%)
chairs reported that they were not living up to their potential in
this area (Q36). Involvement of services in policy review or
development was variable and 9/48 (18%) responding chairs said
that they had not reviewed any policies in the previous
12 months (Q37). Of the 39 services that had reviewed insti-
tutional policies, 36 reported reviewing less than five. Thirteen
committees stated that they had developed policies in the
previous 12 months. Chairs reported a wide variation in the
kinds of policies that their service reviewed or developed, but 22/
49 (45%) had looked at policies regarding end-of-life decisions/
resuscitation/care pathways (Q37).
Service development and evaluation
Just over half of responding chairs (28/47, 60%) identified trust
financial support for members attending external courses or
conferences (Q43). Twenty-three committees had access to in-
house educational workshops. Ten chairs, however, reported no
resources available for education of committee members.
Evaluation of the service was reported by 30/51 (59%) of
responding chairs (Q42). In addition, 35/51 (69%) responding
services submit an annual report (Q40). The most common
forms of evaluation are individual referrer feedback forms for
cases consultation (13/51, 25%), quantitative assessment of the
ethics service’s workload (12/51, 24%) and discussions with
other CEC members (12/51, 24%).
DISCUSSION
In 2001 Slowther et al predicted that the number of CECs in the
UK would increase rapidly.3 At the time of our study there were
82 known CESs in the UK compared with the 20 identified in
2001.3 Our study shows that CESs have increased in number,
and also that their workload and scope have also increased.
Given that the existence of CESs in the UK is the result of
interest within the trust rather than a national recommendation
this increase suggests a growing awareness in NHS trusts of
ethical issues in patient care and the need to address them.
In 2001 most chairs of CECs reported that they concentrated
on guideline and policy development.4 In 2010, while policy
development and review was still an important feature of the
CESs surveyed, only 10% chairs reported spending more than
half of their time on it. The educational function of CECs, seen
in 2001 as important, but difficult to deliver, was still underde-
veloped in 2010. The main change in workload has come from
increased engagement in consultation. In 2001 the eight
committees receiving consultation requests had fewer than two
requests a year.4 In 2010 39% of committees reported receiving
six or more requests a year. Moreover, the scope of consultation
Table 2 Issues that formed the basis of individual case





Withdrawal/withholding treatment 40 (82)
Nutrition and or hydration 31 (63)
Patient/family refusal of treatment 27 (55)
Resource allocation/access to care
(including discharge planning)
24 (49)
Palliative care 20 (41)
Restrictions on patient freedom 19 (39)
Disclosure of patient information 14 (29)
Innovative treatment 9 (18)
Protection of staff 8 (16)
Genetics 7 (14)
Assisted conception 5 (10)
Disclosure of medical error 5 (10)
Assisted dying 4 (8)
Other 7 (14)
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has widened to include institutional concerns as well as
individual clinical cases.
Despite this increase in consultation activity, referral numbers
are still low. This low referral rate has been criticised by some
authors. Whitehead et al have suggested that the low referral
rate reflects some of the difficulties of a committee model for
CESs, citing lack of committee responsiveness as a barrier to
effective and timely support.16 Fox et al, however, found similar
low rates of case referrals in their USA survey, which included
a more varied range of models including individual ethicists and
small group consultation.13 While there is a need for qualitative
research into why referral rates for ethics consultation are low
and which model of support is most effective, the difficulty
might lie less with the model of support and more with the level
of organisational awareness of ethical difficulties and perceived
need for support in resolving them.17 18
A characteristic of CESs in the UK compared with services in
North America and in some European countries is the lack of
regulatory oversight. While CESs in North America are not
regulated directly, the accreditation process for healthcare orga-
nisations requires them to have a mechanism for addressing
ethical issues that arise in provision of patient care and those
mechanisms are evaluated as part of the accreditation process. In
the UK, the lack of regulatory guidance, or indeed of national
recognition of CESs, means that a variety of practices can
proliferate without appropriate support or scrutiny. We consider
some examples below.
Selection and training of members
We found that 39% of surveyed services did not have a selection
process for committee members. The selection of members is
a significant undertaking and should not be left to chance.
Although there is no consensus about the criteria for member-
ship of a CES,19 it is reasonable to expect transparency and
consistency of recruitment and appointment processes.
In 2010 UKCEN published core competencies for CEC
members and similar competency statements have been
published elsewhere most notably by the American Society for
Bioethics and the Humanities (ASBH).20 21 While new members
of CECs need not already possess these competencies they
should be expected to acquire some of them in the near future.
Therefore, it is worrying to note that 20% of services surveyed
received no support from their trust for education of committee
members. Concerns about appropriate training for members of
CESs is not unique to the UK. Gaudine et al found that fewer
than half of Canadian responders reported that their committee
members received special training on joining the committee.14
Fox et al found that 45% of US ethics consultation providers
had learnt independently without direct supervision by an
experienced member of an ethics consultation service.13
Despite legitimate worries about the training and qualification
of CES members it is worth highlighting the presence of at least
one UKCEC member with a masters in clinical or medical ethics
in all services responding to our survey. Whitehead et al found
similar results.16 This is a marked improvement from 2001,
which also compares favourably to US membership. Fox et al
found that only 5% of ethics consultants had completed
a fellowship or a graduate programme in bioethics.13
Referrals and collection of information
The differential access afforded to clinicians and to patients and
their families by UK committees has been noted previously.22
This is not unique to UK CESs and the involvement of patients
and their families in ethics consultation has been debated in
other national contexts.23 24 We also found variation in the
extent to which patients and family members are involved in
the information-gathering process for consultation raising
questions about the quality of the information on which case
deliberations are based. Thus information considered relevant by
patients and families may be omitted, and also the personal
perspectives of patients and families will be excluded, or at best
only be represented second hand.
Further qualitative research is required to explore the reasons
for and consequences of differential access to CESs. Although we
plan to investigate these issues in our future work, one
contributing factor in the UK might be the reason for the
establishment of CESs. CESs in the UK initially developed in
response to a perceived need by clinicians for support in facing
difficult ethical decisions in caring for their patients.3 It is
perhaps not surprising that the primary focus of the service was
to respond to clinicians rather than the wider hospital
community or to patients and families. In countries where there
has been a more top down approach to development of CESs one
might expect the aims of the service to be more broadly set and
access to be more inclusive. For example, in the USA Fox, found
that the stated primary goal in 94% of services was ‘intervening
to protect patients’ rights’.13 Services which articulate this as
their primary goal are more likely to provide access to patients
and their representatives than a service where the primary goal
is clinician support. Thus, it is encouraging that half of UK CESs
provided access to patients, although further work is needed to
explore reasons for the differences between services.
Transparency and accountability
All but one of our responding services required a written referral
for case consultation and all kept written records of consulta-
tions. Less than half (31%), however, recorded the outcome of
the consultation in the patient’s notes and given the variation in
involvement of patients in the consultation process it seems
likely that many patients are unaware of the deliberation that
has taken place about their case. (In the UK an ethics consul-
tation report is considered part of the patient record if it has an
impact on the patient’s care and as such it is available for the
patient to see under the Data Protection Act 1998.)25 Therefore
we suggest there is an obligation on CESs to consider how
patients are informed about this process. The nature of this
obligation; procedural, ethical, legal, or all three, requires further
discussion which is beyond the scope of this paper.
It is encouraging to note that 59% of committees have
performed some sort of evaluation of their service. This statistic
compares favourably to the US and Canadian contexts. Fox et al
found that only 28% of ethics consultation services reported
having a formal evaluation process and Gaudine et al reported
that over 50% of Canadian CECs said that their committees
were not effective in evaluating their activites.13 14 Nonetheless,
the model of evaluation in the UK is variable and we have no
evidence on the robustness of these evaluations. The need for
good evaluative data on CESs has been recognised in the clinical
ethics literature, but little has been done to create the tools for
its provision.26 Providing robust evaluative data is a serious
challenge for all those involved in providing ethics support in
clinical practice and one which must be addressed by CESs in the
UK if they wish to maintain and increase their position in
a changing health service.
Limitations of the study
This study has some important limitations. There is a possibility
that not all clinical ethics services in the UK are registered with
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UKCEN. We think this is unlikely based on our experience of
working with UK CECs over the past 10 years. Unlike hospitals
in the USA, Canada and Norway there is no regulatory or
government requirement for UK healthcare institutions to have
a CES. Therefore, most services are likely to be involved with the
only national body explicitly addressing their needs. An alter-
native sampling method using NHS trusts would be unlikely to
further identify the existence of services not registered with
UKCEN. Although our response rate (62%) is reasonable, our
findings may not be representative of all UK CESs. We did not
receive completed surveys from some regions and we did not
receive any from the three UKCEN registered CESs based in
primary care trusts. Some of the individual questions in our
survey had a low response rate, which may reflect the level of
detailed knowledge that the questions required. Also all of our
respondents were chairs of committees. Although the chair is
likely to be the most knowledgeable informant on the service, he
or she nonetheless provides only one perspective of the
committee’s activities.
CONCLUSION
Clinical ethics services in the UK are increasing as is their
involvement in consultation. This expansion over the past
9 years suggests that there is a perceived place for CESs in the
NHS. While this growth is largely encouraging with it has come
variations in practices and procedures. These differences are not
unique to UK CESs and can be found in similar data from other
countries. Differences in how CESs manage their affairs are not
necessarily problematic as long as the practices are justified. We
suspect, however, that just as CESs have grown throughout the
UK in an ad hoc manner so too have their practices and proce-
dures. Further qualitative research is needed to understand better
how these services conduct their business and why. The devel-
opment of evaluation criteria is also needed. Research evidence
alone, however, is not sufficient to stimulate use of justifiable
practices. As the presence of CESs in the UK increases there is
also a need for national bodies such as the NHS and the
Department of Health to become involved in the coordination of
best practice guidelines. This involvement could take a number
of different forms, but perhaps the most obvious starting point
is the formal recognition of CESs in the UK. If CESs were
recognised as a feature of the NHS it would become easier to put
into place the appropriate support and scrutiny that other
healthcare services require.
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